Compass Therapeutics, Inc. (CMPX) income statement
CMPXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.61+0.00 (+0.71%)
Close on Nov 18, 2026Market cap $110.03MP/E –Yield –
Compass Therapeutics, Inc. financial ratios
See a number that looks wrong?